Affiliation: Stanford University
- HIV and Africa's elderly: the problems and possibilitiesEran Bendavid
Division of General Medical Disciplines, Stanford University, Stanford, California 94305, USA
AIDS 26:S85-91. 2012....
- HIV development assistance and adult mortality in AfricaEran Bendavid
Division of General Medical Disciplines, Center for Health Policy, Stanford University, Stanford, California 94305, USA
JAMA 307:2060-7. 2012..The initiative's effect on all-cause adult mortality is unknown...
- United States aid policy and induced abortion in sub-Saharan AfricaEran Bendavid
Department of Medicine, Stanford University, 251 Campus Drive, Stanford, CA 94305, United States of America
Bull World Health Organ 89:873-880C. 2011..To determine whether the Mexico City Policy, a United States government policy that prohibits funding to nongovernmental organizations performing or promoting abortion, was associated with the induced abortion rate in sub-Saharan Africa...
- Health system determinants of infant, child and maternal mortality: A cross-sectional study of UN member countriesKatherine A Muldoon
British Columbia Centre for Excellence in HIV AIDS, St, Paul s Hospital, 1081 Burrard Street, Vancouver, British Columbia, Canada
Global Health 7:42. 2011..abstract:..
- Comparative analysis of old-age mortality estimations in AfricaEran Bendavid
Division of General Internal Medicine, Stanford University, Stanford, California, United States of America
PLoS ONE 6:e26607. 2011..These estimates are important for social planning and demographic projections. We provide direct estimations of older-age mortality using survey data...
- The relation of price of antiretroviral drugs and foreign assistance with coverage of HIV treatment in Africa: retrospective studyEran Bendavid
Division of General Internal Medicine, Stanford University, Stanford, CA 94305, USA
BMJ 341:c6218. 2010..To determine the association of reductions in price of antiretroviral drugs and foreign assistance for HIV with coverage of antiretroviral treatment...
- Comparative effectiveness of HIV testing and treatment in highly endemic regionsEran Bendavid
Division of General Internal Medicine, Center for Health Policy, Department of Management Science and Engineering, Stanford University, 117 Encina Commons, Stanford, CA 94305 8526, USA
Arch Intern Med 170:1347-54. 2010..Universal testing and treatment holds promise for reducing the burden of human immunodeficiency virus (HIV) in sub-Saharan Africa, but linkage from testing to treatment sites and retention in care are inadequate...
- Cost-effectiveness of antiretroviral regimens in the World Health Organization's treatment guidelines: a South African analysisEran Bendavid
Division of General Internal Medicine, Stanford University, Stanford, USA
AIDS 25:211-20. 2011..the World Health Organization (WHO) recently changed its first-line antiretroviral treatment guidelines in resource-limited settings. The cost-effectiveness of the new guidelines is unknown...
- Expanding antiretroviral options in resource-limited settings--a cost-effectiveness analysisEran Bendavid
Department of Medicine, Center for Health Policy and Center for Primary Care and Outcomes Research, Stanford University, Stanford, CA 94305, USA
J Acquir Immune Defic Syndr 52:106-13. 2009..The effectiveness and cost-effectiveness of increasing the number of antiretroviral regimens is unknown...
- The President's Emergency Plan for AIDS Relief in Africa: an evaluation of outcomesEran Bendavid
Stanford University, Stanford, California, USA
Ann Intern Med 150:688-95. 2009..Since 2003, the President's Emergency Plan for AIDS Relief (PEPFAR) has been the most ambitious initiative to address the global HIV epidemic. However, the effect of PEPFAR on HIV-related outcomes is unknown...
- Cost-effectiveness of HIV monitoring strategies in resource-limited settings: a southern African analysisEran Bendavid
Center for Health Policy and the Center for Primary Care and Outcomes Research, School of Medicine, Stanford University, 117 Encina Commons, Stanford, CA 94305, USA
Arch Intern Med 168:1910-8. 2008..Although the number of infected persons receiving highly active antiretroviral therapy (HAART) in low- and middle-income countries has increased dramatically, optimal disease management is not well defined...
- Complication rates on weekends and weekdays in US hospitalsEran Bendavid
Center for Health Policy, Stanford Medical School, Stanford, Calif 94305, USA
Am J Med 120:422-8. 2007..Recent studies and anecdotal evidence suggest that patient safety may be compromised on weekends. Our objective was to determine whether rates of complications in hospitals are higher on weekends than on weekdays...
- The cost-effectiveness of preexposure prophylaxis for HIV prevention in the United States in men who have sex with menJessie L Juusola
Stanford University, California, USA
Ann Intern Med 156:541-50. 2012..The Centers for Disease Control and Prevention recently provided interim guidance for PrEP in MSM at high risk for HIV. Previous studies did not reach a consistent estimate of its cost-effectiveness...
- The cost-effectiveness of symptom-based testing and routine screening for acute HIV infection in men who have sex with men in the USAJessie L Juusola
Department of Management Science and Engineering, Stanford University, California, USA
AIDS 25:1779-87. 2011..We estimated the effectiveness and cost-effectiveness of strategies to identify and treat acute HIV infection in men who have sex with men (MSM) in the USA...
- Cost effectiveness of screening strategies for early identification of HIV and HCV infection in injection drug usersLauren E Cipriano
Department of Management Science and Engineering, Stanford University, Stanford, California, USA
PLoS ONE 7:e45176. 2012..To estimate the cost, effectiveness, and cost effectiveness of HIV and HCV screening of injection drug users (IDUs) in opioid replacement therapy (ORT)...
- Systematic review: the effects of growth hormone on athletic performanceHau Liu
Santa Clara Valley Medical Center, San Jose, California 95128, USA
Ann Intern Med 148:747-58. 2008..Human growth hormone is reportedly used to enhance athletic performance, although its safety and efficacy for this purpose are poorly understood...
- Characteristics of U.S. emergency departments that offer routine human immunodeficiency virus screeningLaura J Berg
Stanford Kaiser Emergency Medicine Residency, Stanford, CA, USA
Acad Emerg Med 19:894-900. 2012....
- The relationship between HIV testing, stigma, and health service usageSean D Young
Department of Medicine, Division of Infectious Diseases, UCLA, Los Angeles, CA, USA
AIDS Care 22:373-80. 2010..To our knowledge, this is the first study to attempt to use observational data on health service usage for assessing stigma and people's attempts to deal with HIV testing stigma...
- Switch from enfuvirtide to raltegravir in virologically suppressed HIV-1 infected patients: effects on level of residual viremia and quality of lifePhilip M Grant
Stanford University, Division of Infectious Diseases, Palo Alto, CA 94305 5107, USA
J Clin Virol 46:305-8. 2009..Raltegravir is a potential treatment option for virologically suppressed HIV-1 infected patients on enfuvirtide with injection site reactions...
- Risk of Cardiovascular Disease from Antiretroviral Therapy for HIV: A Systematic ReviewClay Bavinger
Center for Primary Care and Outcomes Research, and Center for Health Policy, Stanford University, Stanford, California, United States of America
PLoS ONE 8:e59551. 2013..Recent studies suggest certain antiretroviral therapy (ART) drugs are associated with increases in cardiovascular disease...
- Balancing immunological benefits and cardiovascular risks of antiretroviral therapy: when is immediate treatment optimal?Diana M Negoescu
Department of Management Science and Engineering, Stanford University, CA 94305, USA
Clin Infect Dis 55:1392-9. 2012..If ART reduces HIV progression at high CD4 counts, immediate ART is preferable for most newly infected individuals <35 years even if ART doubles age- and sex-specific cardiac risk...
- Monitoring of antiretroviral therapy in low-resource settingsEran Bendavid
Lancet 372:288-9; author reply 289. 2008
- Hospital workload and adverse eventsJoel S Weissman
Institute for Health Policy, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
Med Care 45:448-55. 2007..Hospitals are under pressure to increase revenue and lower costs, and at the same time, they face dramatic variation in clinical demand...
- Should U.S. hospitals go 24/7?Joel S Weissman
Am J Med 117:202-3. 2004